Why You Should Slather on the Sunscreen
The reason for the sunscreen season is skin cancer prevention. And the most serious skin cancer is melanoma, which will be diagnosed in more than 70,000 people in the next year.
May 22, 2013
Duke Pioneers Gentler Breast Cancer Drugs
Kim Blackwell, MD, leads clinical trials new, more effective, and less toxic treatments for breast cancer. Her work on a new treatment for HER-2 breast cancer, which represents 20 percent of all invasive breast cancers, has drawn international attention.
Oct. 26, 2012
Mammogram Myth Busters
The last thing that should prevent you from having a mammogram is misinformation. Yet many myths persist about mammograms, including who needs them, when to get one, and how effective they are. Here, Jay Baker, M.D., Division Chief of Breast Imaging at Duke University Medical Center, busts the myths that surround mammograms. Read these facts, then share them with your friends and family to make sure they have the most accurate information.
Oct. 19, 2012
Breast Cancer and Exercise Quiz
You probably know that exercising and staying active are important, but do you know how important they are when it comes to reducing your risk for breast cancer? Take this quick quiz to test your knowledge.
Oct. 12, 2012
Prostate Cancer Q&A
A new oral hormone drug for advanced prostate cancer, enzalutamide, is expected to be approved by the U.S. Food and Drug Administration later this year after clinical trials at Duke Cancer Institute and elsewhere demonstrated promising results.
Duke’s Andrew Armstrong, M.D., was co-author of a report published Aug. 15, 2012, in the New England Journal of Medicine showing a 4.8-month improvement in median overall survival, to 18.4 months for patients taking the investigational once-daily pill, compared to 13.6 months for patients taking a placebo.
Sept. 17, 2012
Ovarian Cancer Screening: What Every Woman Needs to Know
News that the risks of ovarian cancer screening tests outweigh the benefits has some women wondering what they should do to prevent the deadly disease. According to the American Cancer Society, ovarian cancer strikes about 22,000 women annually, and kills more than 15,000. While the majority of cases occur in women between the ages of 50 and 75, younger women can be affected as well.
Laura Havrilesky, M.D., a gynecologic oncologist with the Duke Cancer Institute, explains what the latest findings mean and what every woman should know.
Cancer Center Visitation Policy
In the course of the visit it may be clinically or otherwise reasonably necessary for patient care, safety or well-being to impose restrictions on visitation.
Apr. 17, 2012